NCT02484443 2023-10-26Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent OsteosarcomaNational Cancer Institute (NCI)Phase 2 Completed41 enrolled 15 charts
NCT00066365 2015-03-30Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of OsteosarcomaChildren's Oncology GroupPhase 2 Completed49 enrolled 21 charts